176
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Increased blood 8-hydroxy-2-deoxyguanosine levels in methamphetamine users during early abstinence

, MD, PhD, , MD, , MD & , MD, MSc
Pages 395-402 | Received 12 Mar 2017, Accepted 12 Jun 2017, Published online: 20 Jul 2017

References

  • Rawson RA, Condon TP. Why do we need an addiction supplement focused on methamphetamine? Addiction 2007;102:1–4.
  • Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 2005;13:141–154.
  • Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 2008;27:253–262.
  • Lin SK, Huang MC, Lin HC, Pan CH. Deterioration of intelligence in methamphetamine-induced psychosis: comparison with alcohol dependence on WAIS-III. Psychiatry Clin Neurosci 2010;64:4–9.
  • Kuo CJ, Tsai SY, Liao YT, Conwell Y, Lin SK, Chang CL, Chen CC, Chen WJ. Risk and protective factors for suicide among patients with methamphetamine dependence: a nested case-control study. J Clin Psychiatry 2011;72:487–493.
  • Chen CK, Lin SK, Sham PC, Ball D, Lohel W, Murray RM. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet B Neuropsychiatr Genet 2005;136B:87–91.
  • Salamanca SA, Sorrentino EE, Nosanchuk JD, Martinez LR. Impact of methamphetamine on infection and immunity. Front Neurosci 2014;8:445.
  • Huang MC, Yang SY, Lin SK, Chen KY, Chen YY, Kuo CJ, Hung YN. Risk of cardiovascular diseases and stroke events in methamphetamine users: a 10-year follow-up study. J Clin Psychiatry 2016;77:1396–1403.
  • Volkow ND, Fowler JS, Wang GJ, Shumay E, Telang F, Thanos PK, Alexoff D. Distribution and pharmacokinetics of methamphetamine in the human body: clinical implications. Plos One 2010;5:e15269.
  • McDonnell-Dowling K, Kelly JP. The role of oxidative stress in methamphetamine-induced toxicity and sources of variation in the design of animal studies. Curr Neuropharmacol 2017;15:300–314.
  • Kita T, Miyazaki I, Asanuma M, Takeshima M, Wagner GC. Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. Int Rev Neurobiol 2009;88:43–64.
  • Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. Faseb J 2003;17:1195–1214.
  • Cooke MS, Evans MD, Dove R, Rozalski R, Gackowski D, Siomek A, Lunec J, Olinski R. DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat Res 2005;574:58–66.
  • Halliwell B. Why and how should we measure oxidative DNA damage in nutritional studies? How far have we come? Am J Clin Nutr 2000;72:1082–1087.
  • Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2ʹ-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997;387:147–163.
  • Abe T, Isobe C, Murata T, Sato C, Tohgi H. Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson’s disease. Neurosci Lett 2003;336:105–108.
  • Abe T, Tohgi H, Isobe C, Murata T, Sato C. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer’s disease. J Neurosci Res 2002;70:447–450.
  • Ock CY, Kim EH, Choi DJ, Lee HJ, Hahm KB, Chung MH. 8-Hydroxydeoxyguanosine: not mere biomarker for oxidative stress, but remedy for oxidative stress-implicated gastrointestinal diseases. World J Gastroenterol 2012;18:302–308.
  • Sato T, Takeda H, Otake S, Yokozawa J, Nishise S, Fujishima S, Orii T, et al. Increased plasma levels of 8-hydroxydeoxyguanosine are associated with development of colorectal tumors. J Clin Biochem Nutr 2010;47:59–63.
  • Kanauchi M, Nishioka H, Hashimoto T. Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 2002;91:327–329.
  • Forlenza MJ, Miller GE. Increased serum levels of 8-hydroxy-2ʹ-deoxyguanosine in clinical depression. Psychosom Med 2006;68:1–7.
  • Lindqvist D, Dhabhar FS, James SJ, Hough CM, Jain FA, Bersani FS, Reus VI, et al. Oxidative stress, inflammation and treatment response in major depression. Psychoneuroendocrinology 2017;76:197–205.
  • Sato S, Mizuno Y, Hattori N. Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease. Neurology 2005;64:1081–1083.
  • Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997;69:2064–2074.
  • Chen CH, Pan CH, Chen CC, Huang MC. Increased oxidative DNA damage in patients with alcohol dependence and its correlation with alcohol withdrawal severity. Alcohol Clin Exp Res 2011;35:338–344.
  • Winhusen T, Walker J, Brigham G, Lewis D, Somoza E, Theobald J, Somoza V. Preliminary evaluation of a model of stimulant use, oxidative damage and executive dysfunction. Am J Drug Alcohol Abuse 2013;39:227–234.
  • McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005;100:1320–1329.
  • Mirecki A, Fitzmaurice P, Ang L, Kalasinsky KS, Peretti FJ, Aiken SS, Wickham DJ, et al. Brain antioxidant systems in human methamphetamine users. J Neurochem 2004;89:1396–1408.
  • Yamamoto BK, Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J Pharmacol Exp Ther 1998;287:107–114.
  • Huang MC, Lin SK, Chen CH, Pan CH, Lee CH, Liu HC. Oxidative stress status in recently abstinent methamphetamine abusers. Psychiatry Clin Neurosci 2013;67:92–100.
  • Chen WJ, Liu SK, Chang CJ, Lien YJ, Chang YH, Hwu HG. Sustained attention deficit and schizotypal personality features in nonpsychotic relatives of schizophrenic patients. Am J Psychiatry 1998;155:1214–1220.
  • Chen CH, Chen WJ, Cheng AT. Prevalence and identification of alcohol use disorders among nonpsychiatric inpatients in one general hospital. Gen Hosp Psychiatry 2004;26:219–225.
  • Saito S, Yamauchi H, Hasui Y, Kurashige J, Ochi H, Yoshida K. Quantitative determination of urinary 8-hydroxydeoxyguanosine (8-OH-dg) by using ELISA. Res Commun Mol Pathol Pharmacol 2000;107:39–44.
  • Yin B, Whyatt RM, Perera FP, Randall MC, Cooper TB, Santella RM. Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radic Biol Med 1995;18:1023–1032.
  • Giovanni A, Liang LP, Hastings TG, Zigmond MJ. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J Neurochem 1995;64:1819–1825.
  • Johnson Z, Venters J, Guarraci FA, Zewail-Foote M. Methamphetamine induces DNA damage in specific regions of the female rat brain. Clin Exp Pharmacol Physiol 2015;42:570–575.
  • Suriyaprom K, Tanateerabunjong R, Tungtrongchitr A, Tungtrongchitr R. Alterations in malondialdehyde levels and laboratory parameters among methamphetamine abusers. J Med Assoc Thai 2011;94:1533–1539.
  • Govitrapong P, Boontem P, Kooncumchoo P, Pinweha S, Namyen J, Sanvarinda Y, Vatanatunyakum S. Increased blood oxidative stress in amphetamine users. Addict Biol 2010;15:100–102.
  • Alvarenga TA, Andersen ML, Ribeiro DA, Araujo P, Hirotsu C, Costa JL, Battisti MC, Tufik S. Single exposure to cocaine or ecstasy induces DNA damage in brain and other organs of mice. Addict Biol 2010;15:96–99.
  • Cadet JL, Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 1998;32:117–131.
  • Kaye S, McKetin R, Duflou J, Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007;102:1204–1211.
  • Walker J, Winhusen T, Storkson JM, Lewis D, Pariza MW, Somoza E, Somoza V. Total antioxidant capacity is significantly lower in cocaine-dependent and methamphetamine-dependent patients relative to normal controls: results from a preliminary study. Hum Psychopharmacol 2014;29:537–543.
  • Poulsen HE, Nadal LL, Broedbaek K, Nielsen PE, Weimann A. Detection and interpretation of 8-oxodG and 8-oxoGua in urine, plasma and cerebrospinal fluid. Biochim Biophys Acta 2014;1840:801–808.
  • Mena S, Ortega A, Estrela JM. Oxidative stress in environmental-induced carcinogenesis. Mutat Res 2009;674:36–44.
  • Cutler RG. Oxidative stress profiling: part I. Its potential importance in the optimization of human health. Ann N Y Acad Sci 2005;1055:93–135.
  • Irie M, Asami S, Ikeda M, Kasai H. Depressive state relates to female oxidative DNA damage via neutrophil activation. Biochem Biophys Res Commun 2003;311:1014–1018.
  • Hwang ES, Bowen PE. DNA damage, a biomarker of carcinogenesis: its measurement and modulation by diet and environment. Crit Rev Food Sci Nutr 2007;47:27–50.
  • Tata DA, Yamamoto BK. Interactions between methamphetamine and environmental stress: role of oxidative stress, glutamate and mitochondrial dysfunction. Addiction 2007;102:49–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.